Fund shareholders of Oruka Therapeutics Inc
ISIN US6876041087 · United States · LEI 529900TG7O4ESUDMGI54
- Fund shareholders
- 171
- Of which ETFs
- 35 136 other funds
- Value held
- 717.5M $
- Share of capital
- 20.8 % of 66.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,374,750 | 67.4M $ | 0.00 % | 2.08 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 1,006,510 | 34.6M $ | 0.56 % | 1.52 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 944,174 | 46.3M $ | 0.06 % | 1.43 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 761,033 | 37.3M $ | 0.50 % | 1.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 737,386 | 50.4M $ | 2.65 % | 1.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 685,718 | 46.9M $ | 0.56 % | 1.04 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 476,018 | 23.3M $ | 0.21 % | 0.72 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 475,783 | 16.4M $ | 0.31 % | 0.72 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 437,253 | 21.4M $ | 0.03 % | 0.66 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 424,000 | 29M $ | 1.00 % | 0.64 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 407,426 | 14M $ | 0.02 % | 0.62 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 381,549 | 26.1M $ | 0.08 % | 0.58 % | as of Apr 30, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 344,956 | 23.6M $ | 0.34 % | 0.52 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 331,074 | 16.2M $ | 0.13 % | 0.50 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 316,426 | 21.6M $ | 2.09 % | 0.48 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 304,331 | 14.9M $ | 0.18 % | 0.46 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 301,472 | 20.6M $ | 0.41 % | 0.46 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 295,854 | 20.2M $ | 0.47 % | 0.45 % | as of Apr 30, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 214,960 | 14.7M $ | 0.66 % | 0.32 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 213,110 | 14.6M $ | 0.60 % | 0.32 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 204,214 | 7M $ | 0.02 % | 0.31 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 192,270 | 6.6M $ | 0.03 % | 0.29 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 191,127 | 6.6M $ | 0.04 % | 0.29 % | as of Feb 28, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 185,015 | 6.4M $ | 0.10 % | 0.28 % | as of Feb 27, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 162,159 | 8M $ | 0.79 % | 0.24 % | as of Mar 31, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 129,200 | 8.8M $ | 0.01 % | 0.20 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 122,037 | 4.2M $ | 0.02 % | 0.18 % | as of Feb 28, 2026 ↗ |
| Harbor Small Cap Growth Fund HARBOR FUNDS | 110,638 | 7.6M $ | 0.29 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 106,539 | 3.7M $ | 0.02 % | 0.16 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 97,232 | 4.8M $ | 0.39 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 84,596 | 5.8M $ | 0.08 % | 0.13 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 75,797 | 2.6M $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 65,417 | 2.3M $ | 0.01 % | 0.10 % | as of Feb 28, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 63,443 | 2.2M $ | 0.16 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 62,331 | 3.1M $ | 0.06 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 61,904 | 2.1M $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 58,811 | 2M $ | 0.08 % | 0.09 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 56,644 | 2.8M $ | 0.00 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 47,743 | 2.3M $ | 0.13 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 45,589 | 1.6M $ | 0.41 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 44,955 | 3.1M $ | 0.08 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 43,576 | 3M $ | 0.57 % | 0.07 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 43,144 | 1.5M $ | 1.08 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 42,314 | 2.9M $ | 0.02 % | 0.06 % | as of Apr 30, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 40,003 | 2M $ | 0.06 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 34,932 | 2.4M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 29,474 | 1M $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 28,926 | 1.4M $ | 0.21 % | 0.04 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 28,599 | 2M $ | 0.03 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 28,434 | 978.4K $ | 0.09 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 28,323 | 1.9M $ | 1.60 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 26,600 | 1.8M $ | 0.01 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 26,285 | 1.8M $ | 0.88 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Multi-Manager Directional Alternative Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 25,593 | 1.8M $ | 0.55 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 25,028 | 1.2M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 25,000 | 1.2M $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 24,940 | 1.2M $ | 0.13 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 24,105 | 1.6M $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 24,060 | 827.9K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 24,000 | 1.6M $ | 0.01 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 21,737 | 1.1M $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 21,030 | 1M $ | 0.06 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 20,200 | 1.4M $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 19,854 | 1.4M $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 18,676 | 642.6K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 17,896 | 877.8K $ | 0.06 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 17,743 | 1.2M $ | 0.06 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 17,173 | 842.3K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 16,691 | 1.1M $ | 0.08 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 15,468 | 532.3K $ | 0.04 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Tactical Growth Allocation Fund Tactical Investment Series Trust | 14,365 | 704.6K $ | 1.93 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 13,827 | 945.9K $ | 0.04 % | 0.02 % | as of Apr 30, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 13,700 | 672K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 13,486 | 922.6K $ | 0.51 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 13,442 | 659.3K $ | 0.32 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 13,370 | 655.8K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 12,595 | 617.8K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 11,629 | 570.4K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 11,506 | 564.4K $ | 1.44 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 11,212 | 767K $ | 0.08 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 11,025 | 540.8K $ | 0.15 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 10,471 | 513.6K $ | 0.05 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 10,355 | 507.9K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 9,959 | 681.3K $ | 0.02 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 9,945 | 487.8K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 9,143 | 625.5K $ | 1.68 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 9,120 | 447.3K $ | 0.20 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 8,482 | 416K $ | 0.26 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Index Fund Nationwide Variable Insurance Trust | 7,617 | 373.6K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Trust John Hancock Variable Insurance Trust | 7,007 | 343.7K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 6,939 | 340.4K $ | 0.20 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 6,800 | 234K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 6,681 | 327.7K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 6,053 | 414.1K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 5,906 | 404K $ | 0.10 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 5,774 | 283.2K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| DWS Small Cap Index VIP DEUTSCHE DWS INVESTMENTS VIT FUNDS | 5,403 | 265K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| BlackRock Small Cap Index V.I. Fund BlackRock Variable Series Funds, Inc. | 4,754 | 233.2K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NYLI WMC Small Companies Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 4,710 | 322.2K $ | 0.10 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 4,678 | 320K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 2.65 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.09 % | as of Apr 30, 2026 ↗ |
| Tactical Growth Allocation Fund Tactical Investment Series Trust | 1.93 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.68 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.60 % | as of Apr 30, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 1.44 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 1.00 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 0.88 % | as of Apr 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 0.79 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 171 | +39 | 13,771,127 | +11.0 % |
| 2026Q1 | 132 | +23 | 12,405,359 | +26.0 % |
| 2025Q4 | 109 | +25 | 9,849,222 | +3.6 % |
| 2025Q3 | 84 | +43 | 9,508,540 | +20.1 % |
| 2025Q2 | 41 | +8 | 7,918,068 | +32.4 % |
| 2025Q1 | 33 | +17 | 5,981,102 | +199.3 % |
| 2024Q4 | 16 | 1,998,271 |
Institutional managers
176 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 7,431,403 | 364.5M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 4,148,428 | 203.5M $ | as of Mar 31, 2026 |
| Fairmount Funds Management LLC | 3,705,262 | 181.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,527,087 | 173M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 2,666,690 | 130.8M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 2,320,316 | 113.8M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,058,148 | 101M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 2,034,203 | 99.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,613,461 | 79.1M $ | as of Mar 31, 2026 |
| Remedium Capital Partners, LLC | 1,565,661 | 76.8M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,395,501 | 68.4M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,047,693 | 51.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,007,537 | 49.4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,004,056 | 49.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 954,867 | 46.8M $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 802,470 | 39.4M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 760,424 | 37.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 727,449 | 35.7K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 574,882 | 28.2M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 533,340 | 26.2M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 507,008 | 24.9M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 499,673 | 24.5M $ | as of Mar 31, 2026 |
| Synergy Asset Management, LLC | 476,196 | 23.4M $ | as of Mar 31, 2026 |
| SR One Capital Management, LP | 430,330 | 21.1M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 411,006 | 20.2M $ | as of Mar 31, 2026 |
Declared shareholders of Oruka Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Fairmount Funds Management LLC and 4 others | 19.99 % | 13,665,080 | as of Apr 30, 2026 · SCHEDULE 13D |
| VIKING GLOBAL INVESTORS LP and 9 others | 5.30 % | 2,666,690 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Oruka Therapeutics Inc". https://titelia.com/en/stocks/oruka-therapeutics-inc-US6876041087